RICKI BELL: Open Payments
NPI 1932837242 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 54 payments from 13 companies in 2025. Trend: 2023 $445 · 2024 $554 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $241 |
| Janssen Pharmaceuticals, Inc | 3 | $163 |
| Alkermes, Inc. | 5 | $114 |
| Vanda Pharmaceuticals Inc. | 3 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Neurocrine BioSciences, Inc. | 3 | $80 |
| Almatica Pharma LLC | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Corium, LLC | 2 | $52 |
| Lundbeck LLC | 2 | $41 |
Products named: REXULTI, SPRAVATO, FANAPT, CAPLYTA, ARISTADA, INGREZZA, LOREEV XR, Auvelity.
Industry payments across TN — which companies pay providers there.
